Zoetis (ZTS) Change in Cash (2012 - 2026)
Zoetis' (ZTS) quarterly Change in Cash came in at -$509.0 million in Q1 2026, down 53.31% year-on-year from -$1.1 billion in Q1 2025, and down 323.25% on a QoQ basis from $228.0 million in Q4 2025.
Zoetis (ZTS) Change in Cash (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Change in Cash data on file, last reported at -$509.0 million in Q1 2026.
- On a quarterly basis, Change in Cash fell 53.31% year-over-year to -$509.0 million in Q1 2026; TTM through Mar 2026 was $148.0 million, a 146.25% increase from a year earlier, with the FY2025 full-year figure at $325.0 million, up 701.85% from the prior year.
- Change in Cash for Q1 2026 stood at -$509.0 million, down from $228.0 million in the prior quarter.
- Over the last five years, Change in Cash for ZTS reached as high as $1.1 billion in Q4 2022 and fell as low as -$1.5 billion in Q1 2023.
- Historically, Change in Cash has averaged -$98.9 million across 5 years, with a median of -$145.0 million in 2022.
- On a YoY basis, Change in Cash climbed as much as 409.0% in 2022 and fell as far as 17400.0% in 2022.
- Year by year, Change in Cash stood at $1.1 billion in 2022, then tumbled by 73.28% to $287.0 million in 2023, then retreated by 4.88% to $273.0 million in 2024, then decreased by 16.48% to $228.0 million in 2025, then slumped by 323.25% to -$509.0 million in 2026.
- Per Business Quant data, the three most recent Change in Cash figures were -$509.0 million in Q1 2026, $228.0 million in Q4 2025, and $649.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 15.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -509.00 Mn |
| Dec 31, 2025 | 228.00 Mn |
| Sep 30, 2025 | 649.00 Mn |
| Jun 30, 2025 | -220.00 Mn |
| Mar 31, 2025 | -332.00 Mn |
| Dec 31, 2024 | 273.00 Mn |
| Sep 30, 2024 | 140.00 Mn |
| Jun 30, 2024 | -401.00 Mn |
| Mar 31, 2024 | -66.00 Mn |
| Dec 31, 2023 | 287.00 Mn |
| Sep 30, 2023 | 37.00 Mn |
| Jun 30, 2023 | -392.00 Mn |
| Mar 31, 2023 | -1.47 Bn |
| Dec 31, 2022 | 1.07 Bn |
| Sep 30, 2022 | -145.00 Mn |
| Jun 30, 2022 | -483.00 Mn |
| Mar 31, 2022 | -350.00 Mn |
| Dec 31, 2021 | 211.00 Mn |
| Sep 30, 2021 | -384.00 Mn |
| Jun 30, 2021 | 56.00 Mn |